Skip to main content
Clinical Trials/CTRI/2020/07/026824
CTRI/2020/07/026824
Completed
Phase 4

Single blind randomized comparative study comparing clinical equivalence of two polyglactin 910 suture brands, Trusynth�® and Vicryl�®, for subcutaneous tissue closure after cesarean delivery

Healthium Medtech Pvt Ltd0 sites116 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: O80- Encounter for full-term uncomplicated delivery
Sponsor
Healthium Medtech Pvt Ltd
Enrollment
116
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 24, 2021
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Healthium Medtech Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Primiparous or multiparous women aged 18\-40 years with a singleton pregnancy
  • 2\. Women undergoing caesarean section by Pfannenstiel incision
  • 3\. Women with good systemic/ mental health as per opinion of investigator
  • 4\. Women with CDC surgical wound classification class I
  • 5\. Women who have given written informed consent

Exclusion Criteria

  • 1\. Women with hemoglobin levels \<7g/dL
  • 2\. Women who donââ?¬•t require subcutaneous suturing
  • 3\. Women with a history of similar surgical procedure (suprapubic transverse scar, pfannensteil incision, laparoscopic procedure)
  • 4\. Women having urogenital tract infection or chorioamnionitis within 2 weeks before cesarean delivery
  • 5\. Women who will have a stillbirth
  • 6\. Women in whom surgical plan is for a vertical skin incision
  • 7\. Women with history of allergy to the suture materials
  • 8\. Women with history of bleeding disorders
  • 9\. Women already participating in another trial
  • 10\. Women who received an experimental drug or used an experimental medical device within 3 months of becoming pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials